| pubmed-article:8921499 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C0020094 | lld:lifeskim |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C0086427 | lld:lifeskim |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C0240072 | lld:lifeskim |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C0018684 | lld:lifeskim |
| pubmed-article:8921499 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8921499 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8921499 | pubmed:dateCreated | 1997-2-7 | lld:pubmed |
| pubmed-article:8921499 | pubmed:abstractText | Other than adult T-cell leukaemia (ATL) and HTLV-I associated myelopathy (HAM), the health effects of infection with human T-lymphotropic virus type I (HTLV-I) are not well defined. | lld:pubmed |
| pubmed-article:8921499 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8921499 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8921499 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8921499 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8921499 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:8921499 | pubmed:issn | 0300-5771 | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:MurphyJJ | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:MorganO SOS | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:BlattnerW AWA | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:HanchardBB | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:GibbsW NWN | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:WilksRR | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:MurphyE LEL | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:FigueroaJ PJP | lld:pubmed |
| pubmed-article:8921499 | pubmed:author | pubmed-author:CranstonBB | lld:pubmed |
| pubmed-article:8921499 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8921499 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:8921499 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8921499 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8921499 | pubmed:pagination | 1090-7 | lld:pubmed |
| pubmed-article:8921499 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:meshHeading | pubmed-meshheading:8921499-... | lld:pubmed |
| pubmed-article:8921499 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8921499 | pubmed:articleTitle | Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort. | lld:pubmed |
| pubmed-article:8921499 | pubmed:affiliation | Department of Laboratory Medicine, University of California, San Francisco 94143, USA. | lld:pubmed |
| pubmed-article:8921499 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8921499 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8921499 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8921499 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8921499 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8921499 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8921499 | lld:pubmed |
